Gene expression: Page 2

PacBio, Twist Bioscience collaborate to launch long-read gene panels for research

One panel covers nearly 400 challenging genes associated with spinal muscular atrophy, Alzheimer’s, cardiovascular disease, and other diseases.

October 19, 2022

Biofidelity developing assay for single-molecule detection of multiple gene fusions

The firm said its assay analyzes DNA and RNA concurrently from a single patient sample and can return results within two days.

October 18, 2022

Castle Biosciences presents case study on performance of gene expression profile test at CAP22

The test supported the need to perform local excision on a difficult-to-diagnose melanocytic lesion.

October 11, 2022

PerkinElmer highlights cell and gene therapy at SLAS 2022

The company is showcasing work it is doing with new partners Horizon Discovery, BioLegend, Nexcelom Bioscience, and Omni International, which ranges from automation, liquid handling, high-content screening, cell painting, multimode detection, gene editing tools, and functional genomic screening services and libraries. The company is also touting its work in cell counting, antibodies for flow cytometry, recombinant proteins, and no-wash immunoassay kits, PerkinElmer said.

February 6, 2022

Video from ASH 2021: Gene therapy 2.0: The latest in gene editing

The presentations compared new approaches to gene editing with more established approaches in the field, according to Leah Cepko, a science advisor with Science and Medicine Group, parent company of LabPulse.com. Click on the video below to learn more.

December 13, 2021

Mission Bio weaves Tapestri into cell and gene therapy

Tapestri is Mission Bio's proprietary single-cell genotyping and phenotyping platform, which captures single cells for downstream single-cell DNA sequencing -- this can be combined with simultaneous immunophenotyping. Applications for Tapestri in the cell and gene therapy field can include product characterization, on- and off-target editing, editing co-occurrence, and copy-number analysis, among other uses.

November 3, 2021

Most Popular

Quest launches long-COVID testing panels for consumers

Ohio, Kentucky doctors convicted in scheme to bill Medicaid for millions of dollars in unnecessary urinalysis testing

RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target

LumiraDx Q4 revenues drop 65% on lower COVID-19 testing

Patients prefer immediate test results, even when the news is bad

Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux

Sherlock gets $7.5M to create COVID-19 diagnostics

The nondilutive grant funding will help Sherlock further advance its CRISPR gene-editing technology platform, which it used to create its Sherlock CRISPR SARS-CoV-2 detection kit. The funding will also support the development of the company's Inspectr platform, which powers its COVID-19 diagnostic.

May 20, 2020

CRISPR proteins lead to novel POC diagnostics

CRISPR (clustered regularly interspaced short palindromic repeats) represents a bacterial immune system that contains a programmable protein able to cut DNA or RNA. With this technology, genes can be edited and modified in living cells and organisms. While much effort has gone into developing CRISPR to treat disease, CRISPR is also a platform for diagnostics.

February 9, 2020

Microfluidic device could detect Ebola virus earlier

Developed by researcher Ke Du, PhD, at the Rochester Institute of Technology, the device uses clustered regularly interspaced short palindromic repeats (CRISPR) gene-editing technology to monitor and detect RNA markers for Ebola, a highly contagious virus for which there are limited treatments. Individuals in areas where Ebola infections are common are often required to take a blood test before they can travel.

May 5, 2019

Previous Page

Page 2 of 2